News

The new facility will expand Brookwood’s capacity for R&D activities and clinical manufacturing in support of customer projects. Additionally, the building will be SurModics’s corporate center for commercial

The addendum marks the second extension of the agreement signed in 2002, and gives China Medical System Holdings (CMS) the exclusive right to sell Deanxit in China from

As a result, full title to the urokinase assets, including the remaining inventory of finished product, all regulatory and clinical documentation, validated cell lines, and intellectual property rights,

Wyeth’s action is based on its understanding of the Committee for Medicinal Products for Human Use (CHMP) assessment that the Tygacil community-acquired pneumonia (CAP) pivotal clinical trials did

In the re-read of images obtained from previous phase III studies, Epix met all pre-specified endpoints prospectively agreed to with the FDA. Epix plans to resubmit a new

This multi-million dollar research contract will focus on risk assessment and reduction in cardiovascular disease and other disease areas of interest to the customer. Entelos will receive technology

Under the terms of the contract, Acambis will establish a US-based manufacturing capability for ACAM2000, deliver against Centers for Disease Control and Prevention (CDC) orders for a minimum

Paion will be required to make a milestone payment in the event flovagatran receives regulatory approval or is licensed or sold in a major market but will not

Vyvanse, introduced in July 2007 for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 to 12 years, is now said to be the first